Skip to main content
NCBI home page
The British Journal of Ophthalmology logoLink to The British Journal of Ophthalmology
. 1996 Mar;80(3):209–213. doi: 10.1136/bjo.80.3.209

Hyperoxia improves contrast sensitivity in early diabetic retinopathy.

A Harris 1, O Arend 1, R P Danis 1, D Evans 1, S Wolf 1, B J Martin 1
PMCID: PMC505430  PMID: 8703857

Abstract

AIM: The cause of vascular and visual pathology in diabetic retinopathy remains unknown. If retinal hypoxia plays a role, then early in the course of diabetes 100% oxygen breathing should normalise both contrast sensitivity and retinal blood flow. METHODS: This hypothesis was tested in 12 diabetic patients with minimal retinopathy who, none the less, exhibited reduced contrast sensitivity (p = 0.003 versus 12 age and sex-matched controls) and prolonged retinal arteriovenous dye transit (p = 0.0001 versus controls). RESULTS: Isocapnic hyperoxia failed to alter contrast sensitivity in controls, while it significantly improved contrast sensitivity in patients (at 12 cpd; p = 0.042) to levels indistinguishable from normal. Individual improvement in contrast sensitivity correlated positively with the severity of the initial defect (r = +0.84, p = 0.0008). Hyperoxia also had haemodynamic effects; it slowed retinal arteriovenous passage of fluorescein dye in controls, but did not further slow this transit time in patients. CONCLUSIONS: These results demonstrate the reversibility of early contrast sensitivity deficits in diabetes mellitus, and support the hypothesis that factors linked to tissue hypoxia initiate both visual and vascular dysfunction in diabetic retinopathy.

Full text

PDF
209

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Boschi M. C., Frosini R., Mencucci R., Sodi A. The influence of early diabetes on the pattern electroretinogram. Doc Ophthalmol. 1989 Apr;71(4):369–374. doi: 10.1007/BF00152763. [DOI] [PubMed] [Google Scholar]
  2. Di Leo M. A., Caputo S., Falsini B., Porciatti V., Minnella A., Greco A. V., Ghirlanda G. Nonselective loss of contrast sensitivity in visual system testing in early type I diabetes. Diabetes Care. 1992 May;15(5):620–625. doi: 10.2337/diacare.15.5.620. [DOI] [PubMed] [Google Scholar]
  3. Di Leo M. A., Falsini B., Caputo S., Ghirlanda G., Porciatti V., Greco A. V. Spatial frequency-selective losses with pattern electroretinogram in type 1 (insulin-dependent) diabetic patients without retinopathy. Diabetologia. 1990 Dec;33(12):726–730. doi: 10.1007/BF00400342. [DOI] [PubMed] [Google Scholar]
  4. Fallon T. J., Maxwell D. L., Kohner E. M. Autoregulation of retinal blood flow in diabetic retinopathy measured by the blue-light entoptic technique. Ophthalmology. 1987 Nov;94(11):1410–1415. doi: 10.1016/s0161-6420(87)33271-3. [DOI] [PubMed] [Google Scholar]
  5. Feke G. T., Buzney S. M., Ogasawara H., Fujio N., Goger D. G., Spack N. P., Gabbay K. H. Retinal circulatory abnormalities in type 1 diabetes. Invest Ophthalmol Vis Sci. 1994 Jun;35(7):2968–2975. [PubMed] [Google Scholar]
  6. Ghafour I. M., Foulds W. S., Allan D., McClure E. Contrast sensitivity in diabetic subjects with and without retinopathy. Br J Ophthalmol. 1982 Aug;66(8):492–495. doi: 10.1136/bjo.66.8.492. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Greene D. A., Lattimer S. A. Action of sorbinil in diabetic peripheral nerve. Relationship of polyol (sorbitol) pathway inhibition to a myo-inositol-mediated defect in sodium-potassium ATPase activity. Diabetes. 1984 Aug;33(8):712–716. doi: 10.2337/diab.33.8.712. [DOI] [PubMed] [Google Scholar]
  8. Greenstein V., Sarter B., Hood D., Noble K., Carr R. Hue discrimination and S cone pathway sensitivity in early diabetic retinopathy. Invest Ophthalmol Vis Sci. 1990 Jun;31(6):1008–1014. [PubMed] [Google Scholar]
  9. Grunwald J. E., Riva C. E., Baine J., Brucker A. J. Total retinal volumetric blood flow rate in diabetic patients with poor glycemic control. Invest Ophthalmol Vis Sci. 1992 Feb;33(2):356–363. [PubMed] [Google Scholar]
  10. Grunwald J. E., Riva C. E., Brucker A. J., Sinclair S. H., Petrig B. L. Altered retinal vascular response to 100% oxygen breathing in diabetes mellitus. Ophthalmology. 1984 Dec;91(12):1447–1452. doi: 10.1016/s0161-6420(84)34124-0. [DOI] [PubMed] [Google Scholar]
  11. Grunwald J. E., Riva C. E., Sinclair S. H., Brucker A. J., Petrig B. L. Laser Doppler velocimetry study of retinal circulation in diabetes mellitus. Arch Ophthalmol. 1986 Jul;104(7):991–996. doi: 10.1001/archopht.1986.01050190049038. [DOI] [PubMed] [Google Scholar]
  12. Harris A., Arend O., Kopecky K., Caldemeyer K., Wolf S., Sponsel W., Martin B. Physiological perturbation of ocular and cerebral blood flow as measured by scanning laser ophthalmoscopy and color Doppler imaging. Surv Ophthalmol. 1994 May;38 (Suppl):S81–S86. doi: 10.1016/0039-6257(94)90050-7. [DOI] [PubMed] [Google Scholar]
  13. Hyvärinen L., Laurinen P., Rovamo J. Contrast sensitivity in evaluation of visual impairment due to diabetes. Acta Ophthalmol (Copenh) 1983 Feb;61(1):94–101. doi: 10.1111/j.1755-3768.1983.tb01399.x. [DOI] [PubMed] [Google Scholar]
  14. Kern T. S., Kowluru R. A., Engerman R. L. Abnormalities of retinal metabolism in diabetes or galactosemia: ATPases and glutathione. Invest Ophthalmol Vis Sci. 1994 Jun;35(7):2962–2967. [PubMed] [Google Scholar]
  15. Nordmann J. P., Guigui A., Laroche L., Denis P., Saraux H. Sensibilité au contraste et diabète. Bull Soc Ophtalmol Fr. 1990 May;90(5):465–469. [PubMed] [Google Scholar]
  16. Patel V., Rassam S., Newsom R., Wiek J., Kohner E. Retinal blood flow in diabetic retinopathy. BMJ. 1992 Sep 19;305(6855):678–683. doi: 10.1136/bmj.305.6855.678. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Pomerance G. N., Evans D. W. Test-retest reliability of the CSV-1000 contrast test and its relationship to glaucoma therapy. Invest Ophthalmol Vis Sci. 1994 Aug;35(9):3357–3361. [PubMed] [Google Scholar]
  18. Sinclair S. H. Macular retinal capillary hemodynamics in diabetic patients. Ophthalmology. 1991 Oct;98(10):1580–1586. doi: 10.1016/s0161-6420(91)32084-0. [DOI] [PubMed] [Google Scholar]
  19. Sutera S. P., Chang K., Marvel J., Williamson J. R. Concurrent increases in regional hematocrit and blood flow in diabetic rats: prevention by sorbinil. Am J Physiol. 1992 Sep;263(3 Pt 2):H945–H950. doi: 10.1152/ajpheart.1992.263.3.H945. [DOI] [PubMed] [Google Scholar]
  20. Williamson J. R., Chang K., Frangos M., Hasan K. S., Ido Y., Kawamura T., Nyengaard J. R., van den Enden M., Kilo C., Tilton R. G. Hyperglycemic pseudohypoxia and diabetic complications. Diabetes. 1993 Jun;42(6):801–813. doi: 10.2337/diab.42.6.801. [DOI] [PubMed] [Google Scholar]
  21. van Gerven J. M., Tjon-A-Tsien A. M. The efficacy of aldose reductase inhibitors in the management of diabetic complications. Comparison with intensive insulin treatment and pancreatic transplantation. Drugs Aging. 1995 Jan;6(1):9–28. doi: 10.2165/00002512-199506010-00002. [DOI] [PubMed] [Google Scholar]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Publishing Group

RESOURCES